FDA

Study examines whether progestogens used in hormonal contraceptives are linked to an increased risk of meningioma, the most common intracranial tumour in adults.

INESSS is updating its national medical protocol and group prescription template for medication adjustment and monitoring in adults with primary hypertension, and releasing a new guide for clinicians.

Study examines the association between initiation of GLP-1 RAs versus dipeptidyl peptidase-4 inhibitors and fragility fracture risk in adults with type 2 diabetes.

‘This approach would represent a paradigm shift by transforming a common, dose-limiting toxicity into a preventable complication through routine nutritional optimization.’

The association has finalized a recommendation removing certain low-dose bisacodyl suppositories from the National Drug Schedules.

Balancing the benefits of unapproved drug applications with patient safety requires rigorous clinical judgment, informed consent and adherence to medical standards.

A recent global survey found that around 60% of people fear their medicines could be fake—and the unsettling truth is that they have good reason to.

The Alberta College of Pharmacy is emphasizing that patients must receive up-to-date risk information in order to get informed consent.